Study shows that the heart's own immune cells hold potential for the treatment of heart failure

Human heart. Credit: copyright American Heart Association

According to the Centers for Disease Control and Prevention, heart failure affects more than 6 million Americans and is the main cause of death for one in eight patients.

A new study led by University of Minnesota Medical School researcher Xavier Revelo, Ph.D., an assistant professor of integrative biology and physiology, in collaboration with Jop van Berlo, MD, Ph.D., an associate professor of medicine, was recently published in Circulation Research. They suggest that a type of white blood cells known as macrophages play a role in protecting the after injury. Their findings could lead to targeted therapies for heart failure.

"The heart contains various types of that we studied simultaneously using advanced research techniques," Revelo said. "We discovered a large increase in the number of macrophages early in the response to a cardiac injury similar to high blood pressure."

The research team's primary findings were:

  • A cardiac injury similar to leads to a quick increase in the number of cardiac macrophages
  • These cardiac macrophages are important to stimulate new blood vessel formation in the heart
  • Macrophages that reside in the heart are important to prevent scarring or fibrosis of the heart, a process where excessive proteins are deposited around cardiac muscle cells which leads to stiffening of the heart
  • The early increase in macrophages was important to prevent the development of heart failure

Immune cells in the heart are important players in the progression of heart failure and scarring of the heart. While there is currently no cure for heart failure, immune cell targeted therapies hold promise for new treatment avenues for cardiac disease. The results of this study point to a critical role for macrophages in the heart's healing process.

"Immune cells such as macrophages are integral components of the heart where they exert profound effects in healthy and diseased conditions," van Berlo said. "Our new study shows that macrophages that reside in the cardiac tissue, but not those from blood origins, protect the failing heart."

Further research is required to identify the specific means by which the protect the heart and to determine if immunomodulatory therapies are a viable therapeutic option in treating . Revelo says their team has already begun working on those questions.

Study co-authors include U of M graduate students Preethy Parthiban, Chen Chen, Fanta Barrow, Gavin Fredrickson and Doğacan Yücel, Minnesota Supercomputing Institute Analyst Adam Herman, Ph.D., and postdoctoral fellow Haiguang Wang, Ph.D.

Explore further

Researchers find subset of cardiac fibroblasts involved in cardiac inflammation under stress

More information: Xavier Revelo et al, Cardiac Resident Macrophages Prevent Fibrosis and Stimulate Angiogenesis, Circulation Research (2021). DOI: 10.1161/CIRCRESAHA.121.319737
Journal information: Circulation Research

Citation: Study shows that the heart's own immune cells hold potential for the treatment of heart failure (2021, November 12) retrieved 18 January 2022 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors